Media stories about Owens & Minor (NYSE:OMI) have been trending somewhat positive recently, Accern reports. Accern ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Owens & Minor earned a media sentiment score of 0.24 on Accern’s scale. Accern also assigned news articles about the company an impact score of 45.6433007279469 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Shares of Owens & Minor (OMI) traded up 0.36% during mid-day trading on Friday, hitting $28.25. 868,995 shares of the stock traded hands. The firm has a 50 day moving average of $31.26 and a 200 day moving average of $33.38. Owens & Minor has a 12 month low of $27.98 and a 12 month high of $37.02. The stock has a market cap of $1.73 billion, a price-to-earnings ratio of 17.97 and a beta of 1.01.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings results on Tuesday, August 1st. The company reported $0.43 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.43. Owens & Minor had a net margin of 1.02% and a return on equity of 11.64%. The firm had revenue of $2.27 billion for the quarter, compared to the consensus estimate of $2.38 billion. During the same period in the prior year, the firm posted $0.52 earnings per share. The firm’s quarterly revenue was down 8.8% compared to the same quarter last year. On average, equities analysts expect that Owens & Minor will post $1.92 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 15th will be issued a dividend of $0.2575 per share. This represents a $1.03 dividend on an annualized basis and a yield of 3.65%. The ex-dividend date is Thursday, September 14th. Owens & Minor’s dividend payout ratio (DPR) is presently 65.19%.

Several research analysts have weighed in on OMI shares. Zacks Investment Research downgraded shares of Owens & Minor from a “hold” rating to a “sell” rating in a research report on Friday, May 5th. TheStreet downgraded shares of Owens & Minor from a “b” rating to a “c+” rating in a research report on Thursday, May 4th. BidaskClub downgraded shares of Owens & Minor from a “hold” rating to a “sell” rating in a research report on Tuesday, June 20th. Finally, Jefferies Group LLC set a $36.00 price target on shares of Owens & Minor and gave the stock a “hold” rating in a research report on Monday, May 22nd. Three analysts have rated the stock with a sell rating, one has assigned a hold rating and one has assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $31.88.

ILLEGAL ACTIVITY NOTICE: This piece was published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The correct version of this piece can be accessed at

In other Owens & Minor news, SVP Erika T. Davis sold 9,317 shares of the company’s stock in a transaction on Tuesday, May 23rd. The shares were sold at an average price of $32.26, for a total transaction of $300,566.42. Following the completion of the transaction, the senior vice president now directly owns 63,979 shares in the company, valued at $2,063,962.54. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Rony Camil Kordahi sold 2,231 shares of the company’s stock in a transaction on Wednesday, May 24th. The stock was sold at an average price of $32.07, for a total transaction of $71,548.17. Following the transaction, the executive vice president now owns 27,555 shares of the company’s stock, valued at $883,688.85. The disclosure for this sale can be found here. Corporate insiders own 1.68% of the company’s stock.

About Owens & Minor

Owens & Minor, Inc is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).

Insider Buying and Selling by Quarter for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.